These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 2178331)

  • 1. Chemotherapy for medulloblastoma/primitive neuroectodermal tumors of the posterior fossa.
    Packer RJ
    Ann Neurol; 1990 Dec; 28(6):823-8. PubMed ID: 2178331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET.
    Saran F; Baumert BG; Creak AL; Warrington AP; Ashley S; Traish D; Brada M
    Pediatr Blood Cancer; 2008 Mar; 50(3):554-60. PubMed ID: 17941071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Childhood medulloblastoma].
    Yazigi-Rivard L; Masserot C; Lachenaud J; Diebold-Pressac I; Aprahamian A; Avran D; Doz F
    Arch Pediatr; 2008 Dec; 15(12):1794-804. PubMed ID: 18995998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of high-dose chemotherapy for recurrent medulloblastoma and other CNS primitive neuroectodermal tumors.
    Gajjar A; Pizer B
    Pediatr Blood Cancer; 2010 Apr; 54(4):649-51. PubMed ID: 20146223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longterm treatment results of childhood medulloblastoma by craniospinal irradiation in supine position.
    Slampa P; Pavelka Z; Dusek L; Hynkova L; Sterba J; Ondrova B; Princ D; Novotny T; Kostakova S
    Neoplasma; 2007; 54(1):62-7. PubMed ID: 17203894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy.
    Taylor RE; Bailey CC; Robinson KJ; Weston CL; Walker DA; Ellison D; Ironside J; Pizer BL; Lashford LS
    Eur J Cancer; 2005 Mar; 41(5):727-34. PubMed ID: 15763649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [High-dose chemotherapy in relapse of medulloblastoma in young children].
    Dupuis-Girod S; Hartmann O; Benhamou E; Doz F; Mechinaud F; Bouffet E; Coze C; Kalifa C
    Bull Cancer; 1997 Mar; 84(3):264-72. PubMed ID: 9207872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of adjuvant chemotherapy for patients with poor-risk medulloblastoma: a preliminary report.
    Packer RJ; Siegel KR; Sutton LN; Evans AE; D'Angio G; Rorke LB; Bunin GR; Schut L
    Ann Neurol; 1988 Oct; 24(4):503-8. PubMed ID: 3239953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome.
    Butturini AM; Jacob M; Aguajo J; Vander-Walde NA; Villablanca J; Jubran R; Erdreich-Epstein A; Marachelian A; Dhall G; Finlay JL
    Cancer; 2009 Jul; 115(13):2956-63. PubMed ID: 19402050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medulloblastoma: presentation, diagnosis and management.
    Packer RJ; Finlay JL
    Oncology (Williston Park); 1988 Sep; 2(9):35-45, 48-9. PubMed ID: 3275066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of treatment of children with recurrent medulloblastoma/primitive neuroectodermal tumors with lomustine, cisplatin, and vincristine.
    Lefkowitz IB; Packer RJ; Siegel KR; Sutton LN; Schut L; Evans AE
    Cancer; 1990 Feb; 65(3):412-7. PubMed ID: 2153428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.
    Geyer JR; Sposto R; Jennings M; Boyett JM; Axtell RA; Breiger D; Broxson E; Donahue B; Finlay JL; Goldwein JW; Heier LA; Johnson D; Mazewski C; Miller DC; Packer R; Puccetti D; Radcliffe J; Tao ML; Shiminski-Maher T;
    J Clin Oncol; 2005 Oct; 23(30):7621-31. PubMed ID: 16234523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
    Massimino M; Gandola L; Spreafico F; Biassoni V; Luksch R; Collini P; Solero CN; Simonetti F; Pignoli E; Cefalo G; Poggi G; Modena P; Mariani L; Potepan P; Podda M; Casanova M; Pecori E; Acerno S; Ferrari A; Terenziani M; Meazza C; Polastri D; Ravagnani F; Fossati-Bellani F
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1358-63. PubMed ID: 19019566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of site of tumor recurrence upon survival for children with recurrent or progressive medulloblastoma.
    Bowers DC; Gargan L; Weprin BE; Mulne AF; Elterman RD; Munoz L; Giller CA; Winick NJ
    J Neurosurg; 2007 Jul; 107(1 Suppl):5-10. PubMed ID: 17644914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-pineal supratentorial primitive neuro-ectodermal tumors (sPNET) in teenagers and young adults: Time to reconsider cisplatin based chemotherapy after cranio-spinal irradiation?
    Biswas S; Burke A; Cherian S; Williams D; Nicholson J; Horan G; Jefferies S; Williams M; Earl HM; Burnet NG; Hatcher H
    Pediatr Blood Cancer; 2009 Jul; 52(7):796-803. PubMed ID: 19202566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
    Yasuda K; Taguchi H; Sawamura Y; Ikeda J; Aoyama H; Fujieda K; Ishii N; Kashiwamura M; Iwasaki Y; Shirato H
    Jpn J Clin Oncol; 2008 Jul; 38(7):486-92. PubMed ID: 18573848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness of intensive chemotherapy in the treatment of medulloblastoma/primitive neuroectodermal tumor in children].
    Konoplia NE; Strongin IuS; Talabaev MV; Aleĭnikova OV
    Vopr Onkol; 2008; 54(2):157-63. PubMed ID: 18522163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of children under 3 years old with medulloblastoma: a study from the Mexican Cooperative Group for Childhood Malignancies (AMOHP).
    Rivera-Luna R; López E; Rivera-Marquez H; Rivera-Ortegón F; Altamirano-Alvarez E; Mercado G; Covarrubias G; Rueda-Franco F; Marhx-Bracho A; Gutiérrez P
    Childs Nerv Syst; 2002 Feb; 18(1-2):38-42. PubMed ID: 11935242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing of radiation in children with medulloblastoma/PNET.
    Santos MA; Viégas CM; Servidoni RA; Barros MH; Pinel MI; Araújo CM
    Pediatr Blood Cancer; 2007 Apr; 48(4):416-22. PubMed ID: 17034032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma.
    Taylor RE; Bailey CC; Robinson KJ; Weston CL; Ellison D; Ironside J; Lucraft H; Gilbertson R; Tait DM; Saran F; Walker DA; Pizer BL; Lashford LS; ;
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1184-93. PubMed ID: 15001263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.